🟢 MetaVia is trading 6.35% up today during broad-market gains

MetaVia is trading at $1.34, up 6.35%, during a strong broad-market session; no direct link between the market and the stock’s move is established.

• The supplied market context reports the S&P 500 up 1.47%, Nasdaq up 1.63%, and Dow up 2.53%.
• MetaVia is scheduled to present Phase 1 DA-1726 data at the Precision Liver Symposium on November 4. The presentation was announced October 28 and is not confirmed as a new catalyst today.